‘Pervasive Contamination’ Found At Indian Eye Drop Firm Linked To Antibiotic-Resistant Infections

FDA also responds to sting OTC eye drop sector felt with warnings to Amazon after investigators purchased drops labeled with violative claims and a natural health care products firm with Amazon storefront offering drops with ingredient commonly used in joint health supplements and claims to “soften the membranes of the eye.”

• Source: Shutterstock

US regulators apply a major dollop of balm to the black eye the OTC eye drop sector suffered in 2023 with a warning to an Indian firm making numerous products recalled due to contaminations and linked to antibiotic-resistant bacterial infections.

The Food and Drug Administration also responded to the sting the sector’s felt with warnings to e-commerce giant Amazon Inc....

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Compliance

More from Policy & Regulation